RETRACTED: International experience in drug names assessment: European Medicines Agency by A. N. Mironov, I. V. Sakaeva, V. V. Dudchenko, L. V. Korneeva, A. N. Yavorsky

Subjects: Get full text

Requesting conflicts of interest declarations from the European Medicines Agency: 3-year follow-up status by K. Boesen, P. C. Gøtzsche, J. P. A. Ioannidis

Subjects: Get full text

Authorization of Vaccines in the European Union by Ana Hidalgo-Simon, Radu Botgros, Emil Cochino

Subjects: Get full text

Centralized procedure for authorization of veterinary medicinal products by Simona Sturzu

Subjects: Get full text

Biosimilars in India; current status and future perspectives by Bikash R Meher, Sakthi Balan, Rashmi R Mohanty, Monalisa Jena, Smita Das

Subjects: Get full text

Biosimilar insulins – What a clinician needs to know? by Sujoy Ghosh, Saptarshi Bose, Sandeep Gowda, Pradip Mukhopadhyay

Subjects: Get full text

Innovative research methodologies in the EU regulatory framework: an analysis of EMA qualification procedures from a pediatric perspective by Viviana Giannuzzi, Arianna Bertolani, Arianna Bertolani, Silvia Torretta, Giorgio Reggiardo, Eleonora Toich, Donato Bonifazi, Donato Bonifazi, Adriana Ceci, Adriana Ceci

Subjects: Get full text

Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap by Lucia Gozzo, Laura Longo, Daniela Cristina Vitale, Filippo Drago, Filippo Drago, Filippo Drago

Subjects: Get full text

Drug approval processes: A case study of rivaroxaban by Sally A Arif, Zainab Bilfaqi

Subjects: Get full text

Differentiating Agency Independence: Perceptions from Inside the European Medicines Agency by Levan Makhashvili, Paul J Stephenson

Subjects: Get full text

Differentiating Agency Independence: Perceptions from Inside the European Medicines Agency by Levan Makhashvili, Paul J Stephenson

Subjects: Get full text

Data Management in a Regulatory Context by Niels Grønning

Subjects: Get full text

The Iterative Development of Medicines Through the European Medicine Agency's Adaptive Pathway Approach by Giuseppe Nicotera, Gianluca Sferrazza, Annalucia Serafino, Pasquale Pierimarchi

Subjects: Get full text

Human albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis revisited by Christian J. Wiedermann

Subjects: Get full text

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation by Patricia Vella Bonanno, Michael Ermisch, Brian Godman, Brian Godman, Brian Godman, Antony P. Martin, Jesper Van Den Bergh, Liudmila Bezmelnitsyna, Anna Bucsics, Francis Arickx, Alexander Bybau, Tomasz Bochenek, Marc van de Casteele, Eduardo Diogene, Irene Eriksson, Irene Eriksson, Jurij Fürst, Mohamed Gad, Ieva Greičiūtė-Kuprijanov, Martin van der Graaff, Jolanta Gulbinovic, Jolanta Gulbinovic, Jan Jones, Roberta Joppi, Marija Kalaba, Ott Laius, Irene Langner, Ileana Mardare, Vanda Markovic-Pekovic, Vanda Markovic-Pekovic, Einar Magnusson, Oyvind Melien, Dmitry O. Meshkov, Guenka I. Petrova, Gisbert Selke, Catherine Sermet, Steven Simoens, Ad Schuurman, Ricardo Ramos, Jorge Rodrigues, Corinne Zara, Eva Zebedin-Brandl, Alan Haycox

Subjects: “…European Medicines Agency…”
Get full text

Commentary on the draft revised guideline on the environmental risk assessment of medicinal products for human use by Rhys Whomsley, Susanne Brendler-Schwaab, Eadaoin Griffin, John Jensen, Caroline Moermond, Birger Scholz, Laila Sortvik Nilssen, Henry Stemplewski, Ines Roennefahrt

Subjects: Get full text

A decade of collaboration in medicines regulation: healthcare professionals engaging with the European Medicines Agency by Ivana Silva, Giulia Gabrielli, Juan Garcia Burgos, Isabelle Moulon, Gonzalo Calvo Rojas, Ulrich Jaeger, Ulrich Jaeger, Rosa Giuliani

Subjects: “…European Medicines Agency…”
Get full text

Rapid assessment of the reactogenicity of a 2016-2017 seasonal influenza vaccine: results from a feasibility study by Anke L. Stuurman, Thomas Verstraeten, Antoon De Schryver

Subjects: Get full text

Identifying and overcoming challenges in the EMA’s qualification of novel methodologies: a two-year review by Ana Drmić, Riccardo Saccà, Riccardo Saccà, Thorsten Vetter, Falk Ehmann

Subjects: Get full text

Antibodies to watch in 2025 by Silvia Crescioli, Hélène Kaplon, Lin Wang, Jyothsna Visweswaraiah, Vaishali Kapoor, Janice M. Reichert

Subjects: Get full text